Question Title

* 1. Name

Question Title

* 2. Email Address

Question Title

* 3. Was this video an effective way to learn this information?

Question Title

* 4. Did you achieve your objective of participating in the session?

Question Title

* 5. After viewing the roundtable discussion, please indicate your level of agreement about how the review of each study will help you integrate new information into your practice: (Only answer for the studies you viewed)

  Strongly Agree  Agree Neutral Disagree Strongly disagree
A COMPARISON OF THE CONSECUTIVE HOVON-100 AND H-146 STUDIES
PHALLCON TRIAL
REVUMENIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY KMT2AR ACUTE LEUKEMIA
EFFICACY IN NEWLY DIAGNOSED PATIENTS WITH FLT3-ITD+ AML WHO RECEIVED CONTINUATION THERAPY
GENETIC INSIGHTS INTO ACQUIRED RESISTANCE AND CLONAL EVOLUTION IN VEN-BASED THERAPY FOR AML
SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK AML & RESULTS FROM THE HARMONY PLATFORM
ASC4FIRST STUDY

Question Title

* 6. Did you learn something in today's session that will change your clinical practice?

Question Title

* 7. Please identify any potential barriers to implementing clinical changes (check all that apply):

Question Title

* 8. Please provide any suggestions that you feel would have improved this roundtable discussion:

Question Title

* 9. By submitting this form, I consent to my answers being anonymized and aggregated by OncologyEducation and shared with faculty and sponsors to demonstrate the learning effectiveness of these roundtable sessions programs

T